An upcoming study in Richardson, Texas, will investigate potential treatment approaches for agitation in Alzheimer’s disease dementia.
Agitation in Alzheimer's Disease Dementia Research Studies in Richardson, Texas
Clinical Research for Agitation in Alzheimer’s Disease Dementia
Agitation is a common symptom of Alzheimer’s disease dementia, affecting roughly 40% to 60% of people with the condition. It can involve emotional distress, restlessness, pacing, wandering, or repeated movements. Some people may also show verbal aggression, such as yelling, screaming, or repeatedly asking questions. These behaviors can be distressing for both the person with Alzheimer’s disease dementia and their caregivers.
This clinical trial will evaluate a potential new treatment for agitation in people with Alzheimer’s disease dementia. Researchers will assess the safety and efficacy of an investigational drug in the treatment of agitation in participants with Alzheimer’s Disease dementia. The findings may provide researchers with a better understanding of a study treatment for agitation associated with Alzheimer’s disease dementia.
Frequently Asked Questions
1. Who may be eligible for this Alzheimer’s disease dementia study in Richardson, Texas?
The upcoming study is for adults ages 55 to 90 with agitation associated with Alzheimer’s disease dementia. Additional eligibility requirements may apply.
2. What is this clinical trial studying?
This clinical trial will evaluate the safety and efficacy of an investigational treatment for agitation in Alzheimer’s disease dementia.
3. Where will this Alzheimer’s disease dementia study take place?
The upcoming clinical trial will take place in Richardson, Texas.